{"id":"W1996434966","doi":"10.1056/nejmoa040842","title":"Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients","year":2004,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1235,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ribavirin; Medicine; Internal medicine; Peginterferon alfa-2a; Gastroenterology; Hepatitis C; Placebo; Interferon alfa; Hepatitis C virus; Alpha interferon; Interferon; Virology; Immunology; Virus; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02563220288722058,"score_gpt":0.3223026156713883,"score_spread":0.2966704127841677,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}